Abstract:Objective: This study aimed to systematically review the status and trends of Chinese clinical practice guidelines (CPGs) during the time period 2010–2020 and explore their methodological characteristics. Then, based on the strengths and weaknesses in development, offer several recommendations for the quality improvement which will serve as a reference for the users and developers of CPG. Introduction: With the development of evidence-based medicine (EBM), the CPGs play an increasingly important role in healthcare decision-making both in China and worldwide. Inclusion criteria: The CPGs that have been used to help the health professionals in the healthcare decision-making were included. Methodology: The China National Knowledge Infrastructure (CNKI) and WanFang databases were searched from 2010 to 2020 for the studies describing the general and methodological characteristics of Chinese CPGs. Comparisons of the methodological characteristics between the groups were conducted using the chi-square test or Fisher's exact test. The M-K test was adopted to identify the monotonically increasing or decreasing trends of methodological characteristics over the timespan. Results: A total of 2,654 CPGs fulfilled the inclusion criteria. The quantity and quality of the guidelines developed in China have improved over the time span. From 2010 to 2020,the guidelines had differing characteristics and covered a wide range of subjects. In total, 2,318(87.34%) guidelines focused on Western Medicine. Eight (0.30%) had been developed for patient versions of guidelines, 10(0.38%) were tentative guidelines, and 16(0.60%) were rapid advice guidelines. Medical specialty societies (including their branches) (71.1%) were the main guideline makers. The most addressed diseases were neoplasms (14.43%). The target population is mainly adults (84.97%). The methodological quality of consensus-based (CB)-CPGs was obviously lower than evidence-based (EB)-CPGs. Except for the item, “recommendations were based on evidence of systematic reviews,” there were statistical differences in all other methodological items between the EB-CPGS and CB-CPGS ( P < 0.01). Higher methodological quality has been observed in EB-CPGs. All the data relating to the methodological characteristics indicated that higher methodological quality was present in the guidelines using GRADE ( P < 0.01). Conclusion: The quantity and quality of the guidelines developed in China have improved between 2010 and 2020. CB-CPGs have also paid attention to the methodology quality, but obviously, this is lower than that in the EB-CPGs.

Rethinking and Exploring the Comprehensive Evaluation of Clinical Practice Guidelines

Development of the Scientific, Transparent and Applicable Rankings (STAR) tool for clinical practice guidelines

[Development of a Ranking Tool for Scientificity, Transparency and Applicability of Clinical Practice Guidelines].

Challenges and Strategies for Implementing the STAR Tool for Comprehensive Evaluation of Guidelines: A Qualitative Study with Chinese Clinicians.

Quality of Critical Care Clinical Practice Guidelines: Assessment with AGREE II Instrument.

The Quality of Clinical Practice Guidelines in China: a Systematic Assessment.

Quality Assessment of Clinical Guidelines in China: 1993 - 2010.

Appraising the quality of clinical practice guidelines in traditional Chinese medicine using AGREE II instrument: A systematic review

Methodology of Scientific,Transparent and Applicable Rankings for Chinese Guidelines and Consensus Related Literature Published in the Medical Journals:Sample Identification and Speciality Assignment

Development and Preliminary Verification of the Evaluation System for Clinical Practice Guidelines in China

An appraisal of clinical practice guidelines for constipation: a right attitude towards to guidelines

How to Appraise and Implement Clinical Practice Guideline for Clinicians

Analysis of the Status and Trends of Chinese Clinical Practice Guideline Development Between 2010 and 2020: A Systematic Review

An Instrument for Evaluating the Clinical Applicability of Guidelines

Clinical practice guidelines of Chinese patent medicine in China: A critical review

Reporting Quality Evaluation of the Stroke Clinical Practice Guidelines: a Systematic Review.

[Development of Clinical Practice Guidelines: Procedure and Standard].

Clinical practice guideline in China: current status and thoughts

Quality problems in clinical practice guidelines and guideline appraisal studies: Should we tolerate or eradicate?

Clinical Practice Guidelines for Hypertension: Evaluation of Quality Using the AGREE II Instrument

Development of the Implementability Assessment Tool for Clinical Practice Guidelines Based on the COSMIN Framework and Factorial Experiment: a Study Protocol